Self-assembled IR780-loaded transferrin nanoparticles as an imaging, targeting and PDT/PTT agent for cancer therapy

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Wang, Kaikai ^a,b   Zhang, Yifan ^a   Wang, Juan ^a   Yuan, Ahu ^a   Sun, Minjie ^b   Wu, Jinhui ^a,b,c   Hu, Yiqiao ^a,c  

^a MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

^b CHINA PHARMACEUTICAL UNIVERSITY   (China)

^c NANJING UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

2-(2-(2-CHLORO-3-((1,3-DIHYDRO-3,3-DIMETHYL-1-PROPYL-2H-INDOL-2-YLIDENE)ETHYLIDENE)-1-CYCLOHEXEN-1-YL)ETHENYL)-3,3-DIMETHYL-1-PROPYLINDOLIUM; INDOLE DERIVATIVE; NANOPARTICLE; TRANSFERRIN;

ANIMAL; BAGG ALBINO MOUSE; CHEMISTRY; MALE; MOUSE; NEOPLASM; PHOTOCHEMOTHERAPY; PHOTOTHERAPY; PROCEDURES; THERMOTHERAPY; ULTRAVIOLET SPECTROPHOTOMETRY;

ANIMALS; HYPERTHERMIA, INDUCED; INDOLES; MALE; MICE; MICE, INBRED BALB C; NANOPARTICLES; NEOPLASMS; PHOTOCHEMOTHERAPY; PHOTOTHERAPY; SPECTROPHOTOMETRY, ULTRAVIOLET; TRANSFERRIN;

EID: 84973370397     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep27421     Document Type: Article

References (44)

1. Dougherty, T. J. et al. Photodynamic therapy. J Natl Cancer Inst 90, 889-905 (1998).
2. Chatterjee, D. K., Fong, L. S. & Zhang, Y. Nanoparticles in photodynamic therapy: an emerging paradigm. Adv Drug Deliv Rev 60, 1627-1637 (2008).
3. Lucky, S. S., Soo, K. C. & Zhang, Y. Nanoparticles in photodynamic therapy. Chem Rev 115, 1990-2042 (2015).
4. Dolmans, D. E., Fukumura, D. & Jain, R. K. Photodynamic therapy for cancer. Nat Rev Cancer 3, 380-387 (2003).
5. Allison, R. R. et al. Photosensitizers in clinical PDT. Photodiagnosis and photodynamic therapy 1, 27-42 (2004).
6. Kempa, M. et al. Physicochemical properties of potential porphyrin photosensitizers for photodynamic therapy. Spectrochim Acta A Mol Biomol Spectrosc 146, 249-254 (2015).
7. Baron, E. D. et al. Silicon phthalocyanine (Pc 4) photodynamic therapy is a safe modality for cutaneous neoplasms: results of a phase 1 clinical trial. Lasers in surgery and medicine 42, 728-735 (2010).
8. Costagliola, C. et al. Verteporfin photodynamic therapy for subfoveal choroidal neovascularization in pathologic myopia: a 12-month retrospective review. European journal of ophthalmology 18, 955-959 (2008).
9. Jones, H. J., Vernon, D. I. & Brown, S. B. Photodynamic therapy effect of m-THPC (Foscan) in vivo: correlation with pharmacokinetics. British journal of cancer 89, 398-404 (2003).
10. Kujundzic, M. et al. A Phase II safety and effect on time to tumor progression study of intratumoral light infusion technology using talaporfin sodium in patients with metastatic colorectal cancer. Journal of surgical oncology 96, 518-524 (2007).
11. Wang, W., Moriyama, L. T. & Bagnato, V. S. Photodynamic therapy induced vascular damage: an overview of experimental PDT. Laser Physics Letters 10, 023001 (2012).
12. Sitnik, T. M., Hampton, J. A. & Henderson, B. W. Reduction of tumour oxygenation during and after photodynamic therapy in vivo: effects of fluence rate. British journal of cancer 77, 1386-1394 (1998).
13. Zhang, M. et al. Fabrication of ZnPc/protein nanohorns for double photodynamic and hyperthermic cancer phototherapy. Proc Natl Acad Sci USA 105, 14773-14778 (2008).
14. Lin, J. et al. Photosensitizer-loaded gold vesicles with strong plasmonic coupling effect for imaging-guided photothermal/photodynamic therapy. Acs Nano 7, 5320-5329 (2013).
15. Tian, B., Wang, C., Zhang, S., Feng, L. & Liu, Z. Photothermally enhanced photodynamic therapy delivered by nano-graphene oxide. Acs Nano 5, 7000-7009 (2011).
16. Yuan, A. et al. Application of near-infrared dyes for tumor imaging, photothermal, and photodynamic therapies. J Pharm Sci 102, 6-28 (2013).
17. Schaafsma, B. E. et al. The Clinical Use of Indocyanine Green as a Near-Infrared Fluorescent Contrast Agent for Image-Guided Oncologic Surgery. Journal of surgical oncology 104, 323-332 (2011).
18. Bahmani, B., Bacon, D. & Anvari, B. Erythrocyte-derived photo-theranostic agents: hybrid nano-vesicles containing indocyanine green for near infrared imaging and therapeutic applications. Scientific reports 3, 2180 (2013).
19. Wang, Y. et al. Preferential accumulation of the near infrared heptamethine dye IR-780 in the mitochondria of drug-resistant lung cancer cells. Biomaterials 35, 4116-4124 (2014).
20. Yue, C. X. et al. IR-780 dye loaded tumor targeting theranostic nanoparticles for NIR imaging and photothermal therapy. Biomaterials 34, 6853-6861 (2013).
21. Zhang, C. et al. Sentinel lymph node mapping by a near-infrared fluorescent heptamethine dye. Biomaterials 31, 1911-1917 (2010).
22. Wilk, K. A. et al. Photo-oxidative action in MCF-7 cancer cells induced by hydrophobic cyanines loaded in biodegradable microemulsion-templated nanocapsules. Int J Oncol 41, 105-116 (2012).
23. Yhee, J. Y. et al. Tumor-targeting transferrin nanoparticles for systemic polymerized siRNA delivery in tumor-bearing mice. Bioconjugate chemistry 24, 1850-1860 (2013).
24. Wang, K., Yuan, A., Yu, J., Wu, J. & Hu, Y. One-Step Self-Assembling Method to Prepare Dual-Functional Transferrin Nanoparticles for Antitumor Drug Delivery. J Pharm Sci (2016).
25. Hopkins, C. R., Miller, K. & Beardmore, J. M. Receptor-mediated endocytosis of transferrin and epidermal growth factor receptors: a comparison of constitutive and ligand-induced uptake. Journal of cell science. Supplement 3, 173-186 (1985).
26. Choi, C. H., Alabi, C. A., Webster, P. & Davis, M. E. Mechanism of active targeting in solid tumors with transferrin-containing gold nanoparticles. Proc Natl Acad Sci USA 107, 1235-1240 (2010).
27. Kawamoto, M., Horibe, T., Kohno, M. & Kawakami, K. A novel transferrin receptor-targeted hybrid peptide disintegrates cancer cell membrane to induce rapid killing of cancer cells. Bmc Cancer 11 (2011).
28. Nakase, I. et al. Transferrin receptor-dependent cytotoxicity of artemisinin-transferrin conjugates on prostate cancer cells and induction of apoptosis. Cancer letters 274, 290-298 (2009).
29. Qian, Z. M., Li, H. Y., Sun, H. Z. & Ho, K. Targeted drug delivery via the transferrin receptor-mediated endocytosis pathway. Pharmacol Rev 54, 561-587 (2002).
30. Zhang, Y., Huo, M., Zhou, J. & Xie, S. PKSolver: An add-in program for pharmacokinetic and pharmacodynamic data analysis in Microsoft Excel. Comput Methods Programs Biomed 99, 306-314 (2010).
31. Gong, G. et al. Curcumin-incorporated albumin nanoparticles and its tumor image. Nanotechnology 26, 045603 (2015).
32. Gong, G. et al. Molecular switch for the assembly of lipophilic drug incorporated plasma protein nanoparticles and in vivo image. Biomacromolecules 13, 23-28 (2012).
33. Gong, G. et al. Fabrication of a nanocarrier system through self-assembly of plasma protein and its tumor targeting. Nanotechnology 22, 295603 (2011).
34. Wang, S. D. et al. Self-assembly of plasma protein through disulfide bond breaking and its use as a nanocarrier for lipophilic drugs. Polym Chem-Uk 5, 4871-4874 (2014).
35. Wang, K., Yuan, A., Yu, J., Wu, J. & Hu, Y. One-Step Self-Assembling Method to Prepare Dual-Functional Transferrin Nanoparticles for Antitumor Drug Delivery. J Pharm Sci 105, 1269-1276 (2016).
36. Wang, K. K. et al. Acid Denaturation Inducing Self-Assembly of Curcumin-Loaded Hemoglobin Nanoparticles. Materials 8, 8701-8713 (2015).
37. Jiang, W., Kim, B. Y. S., Rutka, J. T. & Chan, W. C. W. Nanoparticle-mediated cellular response is size-dependent. Nat Nanotechnol 3, 145-150 (2008).
38. Jang, B., Park, J. Y., Tung, C. H., Kim, I. H. & Choi, Y. Gold Nanorod-Photosensitizer Complex for Near-Infrared Fluorescence Imaging and Photodynamic/Photothermal Therapy In Vivo. Acs Nano 5, 1086-1094 (2011).
39. Sheng, Z. H. et al. Smart Human Serum Albumin-Indocyanine Green Nanoparticles Generated by Programmed Assembly for Dual-Modal Imaging-Guided Cancer Synergistic Phototherapy. Acs Nano 8, 12310-12322 (2014).
40. Chen, Q. et al. Near-infrared dye bound albumin with separated imaging and therapy wavelength channels for imaging-guided photothermal therapy. Biomaterials 35, 8206-8214 (2014).
41. Engel, E. et al. Light-induced decomposition of indocyanine green. Invest Ophth Vis Sci 49, 1777-1783 (2008).
42. Aravind, A. et al. AS1411 aptamer tagged PLGA-lecithin-PEG nanoparticles for tumor cell targeting and drug delivery. Biotechnol Bioeng 109, 2920-2931 (2012).
43. Daniels, T. R. et al. The transferrin receptor and the targeted delivery of therapeutic agents against cancer. Biochim Biophys Acta 1820, 291-317 (2012).
44. Jiang, C. et al. Hydrophobic IR780 encapsulated in biodegradable human serum albumin nanoparticles for photothermal and photodynamic therapy. Acta Biomater 14, 61-69 (2015).